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De novo copy-number variants (CNVs) can cause
neuropsychiatric disease, but the degree to which
they occur somatically, and during development,
is unknown. Single-cell whole-genome sequencing
(WGS) in >200 single cells, including >160 neurons
from three normal and two pathological human
brains, sensitively identifiedgermline trisomyof chro-
mosome 18 but found most (R95%) neurons in
normal brain tissue tobeeuploid. Analysis of apatient
with hemimegalencephaly (HMG) due to a somatic
CNV of chromosome 1q found unexpected tetras-
omy 1q in 20% of neurons, suggesting that CNVs
in a minority of cells can cause widespread brain
dysfunction. Single-cell analysis identified large
(>1 Mb) clonal CNVs in lymphoblasts and in single
neurons from normal human brain tissue, suggesting
that some CNVs occur during neurogenesis. Many
neurons contained one or more large candidate pri-
vate CNVs, including one at chromosome 15q13.2-
13.3, a site of duplication in neuropsychiatric
conditions. Large private and clonal somatic CNVs
occur in normal and diseased human brains.
INTRODUCTION
Several recent studies have implicated somatic mutations in
a range of diseases, including neurodevelopmental disorders
(Biesecker and Spinner, 2013; Jamuar et al., 2014; Poduri
et al., 2013; Veltman and Brunner, 2012), with the manifestations
of somatic disorders determined by the mutation, its prevalence
in the tissue, and the time point during development when
the mutation occurred (Poduri et al., 2013). Single-nucleotide
variants (SNVs) and copy-number variants (CNVs) arising during1280 Cell Reports 8, 1280–1289, September 11, 2014 ª2014 The Auprenatal brain development have been linked to brain malforma-
tions such as hemimegalencephaly (HMG), in which one hemi-
sphere of the brain is abnormally enlarged, resulting in severe
neurological defects, including epilepsy and intellectual disability
(Lee et al., 2012; Poduri et al., 2012).
Somatic aneuploidy has been proposed as a mechanism to
generate normal genetic diversity in neurons (Bushman and
Chun, 2013). Previous reports suggested aneuploidy rates of
1.3%–40%, potentially increasing with age (Kingsbury et al.,
2005). Advances in single-cell genomics allow direct assess-
ment of single neuronal genomes from postmortem human
brains, enabling systematic characterization of somatic aneu-
ploidies and subchromosomal CNVs (Evrony et al., 2012; Gole
et al., 2013; McConnell et al., 2013).
Since all current single-cell studies rely on genome amplifica-
tion, which introduces biases and artifacts, we performed CNV
analysis of single human neurons using two different methods:
multiple displacement amplification (MDA)-based single-cell
whole-genome amplification (scWGA) (Evrony et al., 2012;
Wang et al., 2012; Xu et al., 2012) and a PCR-based method
known as GenomePlex, marketed by Sigma (Van der Aa et al.,
2013; Voet et al., 2013; Yin et al., 2013). Our analysis of single
neuronal genomes from normal and diseased human brains with
both MDA and GenomePlex shows, consistent with recent re-
ports, that somatic aneuploidy is rare but somatic CNVs are not
rare (Gole et al., 2013; McConnell et al., 2013). We also show
that clonal somatic CNVs exist both in normal brain and in HMG.
RESULTS
scWGA by MDA and GenomePlex
We isolated single neuronal nuclei by fluorescence-activated cell
sorting (FACS) as previously described (Evrony et al., 2012), us-
ing NeuN immunoreactivity to identify neurons, and comprehen-
sively compared MDA and GenomePlex. Single neuronal nuclei
or pooled 100-neuronal nuclei samples from three normal
adult human brains (UMB1465, UMB4638, and UMB4643), onethors
trisomy 18 (tri18) fetal brain (UMB866), and single lymphoblast
cells (GM21781) were subjected to either MDA or GenomePlex,
followed by low-coverage whole-genome sequencing (WGS)
and CNV analysis (Table S1). Amplification uniformity was as-
sessed by the distribution of copy-number (CN) ratios (CNRi)
of 6,000 ‘‘equal-read’’ bins across the genome (Baslan et al.,
2012). Compared to unamplified ‘‘bulk’’ DNA, one-cell and
100-cell samples subjected to MDA or GenomePlex showed
significantly nosier CN profiles, suggesting that both methods
introduce amplification noise (Figure 1; Figure S1). However,
after GC normalization, the amplification noise did not show
obvious bias to any particular genomic region at 500 kb reso-
lution (Figure S1D), with the exception of chromosome 19 by
MDA, which shows systematically reduced CN (not shown).
Amplification noise introduced by GenomePlex was noticeably
lower than MDA, such that amplification of a single cell with
GenomePlex produced noise similar in magnitude to pooled
100-cell samples amplified with MDA (Figures 1B and 1C; Fig-
ure S1) (Van der Aa et al., 2013).
Measuring Amplification Quality with a Median Absolute
Pairwise Difference Algorithm
In order to quantitate CN noise, we adapted a QC metric
designed for microarray data, the median absolute pairwise dif-
ference (MAPD) algorithm (Affymetrix, 2008). MAPD measures
the absolute difference between the log2 CN ratios of every
pair of neighboring bins and then takes the median across all
bins. Higher MAPD scores reflect greater noise, typically associ-
ated with poor-quality samples. MAPD provides significant ad-
vantages over other standard sample deviation measures such
as SD, median absolute deviation, and interquartile range, since
it is more robust to the presence of real CNVs.
As expected, unamplified bulk samples showed the best
(lowest) MAPD scores (mean = 0.06 ± 0.02, n = 3), and the
MAPD scores of GenomePlex-amplified one-cell samples
(mean = 0.20 ± 0.05, n = 54) were consistently lower than MDA
one-cell samples (mean = 0.45 ± 0.17, n = 89) (Figure 1B; see
also Figure S1E), consistent with the tighter distribution of CN
ratios previously observed with PicoPlex/GenomePlex (Figures
1A and 1B) (Voet et al., 2013). In addition to the higher MAPD
scores seen in MDA samples, there was a tail of MDA samples
with very high MAPD scores, suggesting poor or nonuniform
amplification (Figure 1B; see also Figure S1E). In fact, all MDA
samples were subjected to an initial multiplex-PCR sample qual-
ity control (QC) prior to sequencing analysis (Figure S1A), and all
the samples that failed this initial QC also had highMAPD scores
(not shown), suggesting that the MAPD reliably measures the
quality of the amplified genome.
We tested different genomic bin sizes to optimize the ability of
single-cell WGS to detect CNVs, using the MAPD as a guide.
With decreasing bin sizes, including 500 kb, 150 kb, and
60 kb (with comparable read counts per bin), MAPD scores
increased for both methods, suggesting greater noise with
smaller bin sizes (Figure 1C). Such change in CN noise is not
due to Poisson error of sequencing depth, because the number
of read counts in each bin at various bin sizes is comparable, and
because MAPD scores from unamplified bulk samples do not
change with bin size (Figure 1C). Although MDA always gaveCell Rehigher MAPD scores, this can be partially compensated by
increasing bin size, at the cost of CNV resolution. MAPD scores
of MDA samples with 500 kb bins were similar to GenomePlex
samples at60 kb bin size (0.33 ± 0.02 and 0.33 ± 0.01, respec-
tively; error = ±SD) (Figure 1C). For CN profiling in MDA single-
cell samples, 500 kb bin sizes represent a compromise that
should reliably detect megabase-sized CNVs, sufficient for chro-
mosomal aneuploidy and large CNV studies, while analysis of
smaller CNVs is limited to GenomePlex samples.
Chromosomal Aneuploidy Analysis of Single Neurons
A total of 215 cells were analyzed, including 97 single neurons
from three normal adults, 18 single cells from a tri18 fetus, 24
culturedsingle lymphoblast cells fromanormal adult, and46neu-
rons and 30 non-neuronal cells from a patient with HMG and a
somatic chromosome 1q CNV (Table S1). Only samples with
MAPD% 0.45were included in genome-wideCNVanalyses (Fig-
ure 1B), which included all GenomePlex samples. MAPD scores
of MDA samples varied between different individuals (Figure 1B;
see also Figure S1F), suggesting that postmortem interval, tissue
handling, and other factors may influence DNA integrity and
amplification. This intersample variability highlights the impor-
tance of quality controls prior to single-cell analyses and sug-
gests low-coverage single-cell CNV analysis as a method to
assess the quality of postmortem tissues for single-cell studies.
A total of 9 of 18 tri18 single neurons amplified byMDA passed
the MAPD quality control, and all nine showed estimated CN of
3 at chromosome 18 (average CN of all tri18 single neurons =
3.01 ± 0.17 at chromosome 18) (Figure 2A; see also Figures
S2A–S2C), with no strong evidence for aneuploidy of other chro-
mosomes. The 100% sensitivity and specificity in calling tri18
shows the ability of single-cell WGS to detect large chromo-
somal CNVs after MDA. In contrast, of 82 single cortical neurons
(from three normal individuals) with MAPD % 0.45 amplified by
either MDA or GenomePlex, 78 out of 82 were euploid (95.1%)
(Figure 1B). No neurons showed discrete, integral CNV of an
entire chromosome suggestive of simple trisomy or monosomy.
Instead, three neurons showed genome-wide CN imbalances
(Figures S2D–S2G) not limited to a single method or individual.
Similar observations from other labs with both methods suggest
that these cells are unlikely to represent simple aneuploidy, but
their interpretation is uncertain (Baslan et al., 2012; McConnell
et al., 2013). One neuron amplified byMDA showed an equivocal
CN change at chromosome 19 (data not shown), but the system-
atic bias seen at chromosome 19 acrossMDA samples suggests
that this might reflect a technical artifact.
Analysis of a Large, Clonal, Pathogenic Somatic CNV
HMG is a brain overgrowth syndrome caused in some cases by
brain-specific somatic SNVs or somatic CNVs of chromosome
1q (Lee et al., 2012; Poduri et al., 2012). Two cases previously
studied by us showed a mosaic CN increase at chromosome
1q, originally interpreted as mosaic trisomy of 1q (Poduri et al.,
2012). Neuronal and non-neuronal 100-cell MDA samples
showed intermediate CN gain of the chromosome 1q arm in
both populations (Figures 2B and 2C; see also Figures S2H
and S2I), estimated at 2.35 and 2.7, respectively. This result
confirmed the mosaic gain and suggested that the CNV aroseports 8, 1280–1289, September 11, 2014 ª2014 The Authors 1281
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Figure 1. CN Analysis from Low-Coverage WGS
(A) Comparison of WGS CN analysis in unamplified DNA, single-cell MDA, and single-cell GenomePlex. The x axis represents 6,000 bins across the genome. The
yaxis represents the log2CNratioof eachbin relative to theexpectedCNbasedonasimulated reference (seeExperimentalProcedures).Blackdashed lines indicate
CNof 2andorangedashed lines indicateCNof 1and3.Eachchromosome isdividedbyvertical linesand labeledon topof thegraph.Note thatunamplifiedbulkDNA
gives the clearest signal, while single-cell samples are noisier, especially MDA, but still allow recognition of sex chromosome differences in these male samples.
(B) MAPD scores for WGS CN analysis of unamplified DNA samples, and single-cell genomes analyzed using GenomePlex or MDA. The histogram showsMAPD
scores of all sequenced samples from normal individuals. Bulk (unamplified) DNA gives the best (lowest) MAPD scores (mean = 0.06 ± 0.02, n = 3), whereas
GenomePlex (mean = 0.20 ± 0.05, n = 54) gives generally lower MAPD scores than MDA (mean = 0.45 ± 0.17, n = 89), and MDA samples form a long tail of high
MAPD scores suggesting low quality (also see Figure S1). Most samples were called euploid (n = 111) and fewer were called aneuploid (n = 17), and most
aneuploid cells had highMAPD scores suggesting unreliable calls. A total of 113 samples passedMAPD threshold% 0.45 (red dash line) and 15 samples failed, all
amplified by MDA, including three that failed initial multiplex-PCR quality control. Among samples with MAPD% 0.45, 109 out of 113 were euploid and 4 out of
113 were potentially aneuploid.
(C) Effect of bin size onCNdata noise. AverageMAPDscore of bulk,MDA, andGenomePlex single-cell samples plotted for 500 kb (6,000 bins total), 150 kb (20,000
bins), and60kb (50,000bins) bins. At eachbin size, the average readsper bin is normalized to500 forMDAand250 forGenomePlex andbulk samples.MAPDof
both MDA and GenomePlex samples increases with decreasing average bin size, whereas the MAPD score of bulk DNA remains unchanged with bin sizes,
suggesting that both amplifications introduce more prominent noise at smaller local regions (n = 2 for bulk; n = 4 for MDA single cells; n = 1 for MDA 100-cell; and
n = 4 for GenomePlex single cells; error bar,±SD). The red dashed line indicates that theCNnoise ofMDA samples at 500 kbbin size is comparable to theCNnoise
of GenomePlex single-cell samples at 60 kb average bin size; MAPD scores equal 0.33 ± 0.02 and 0.33 ± 0.01 (error = ±SD), respectively. The increased noise
fromMDA samples can be partially compensated by reducing CN resolution. GenomePlex data are from Navin et al. (2011), due to insufficient sequencing depth
of our own GenomePlex data, and were used to compare with four wild-type single-cortical neurons and one 100-caudate neuron sample amplified by MDA.in a cell giving rise to both neurons and non-neuronal cells,
similar to our previous observation of a mosaic E17K point muta-
tion in AKT3 (Evrony et al., 2012).
CNV analysis of single nuclei from the brain of HMG-1, known
to have been through multiple freeze-thaw cycles before anal-1282 Cell Reports 8, 1280–1289, September 11, 2014 ª2014 The Auysis, was complicated by poor tissue preservation, reflected
in the FACS scatterplot of HMG-1 (data not shown). Many
HMG-1 cells amplified poorly and did not pass the MAPD
QC threshold. Of 46 single neurons (NeuN+) sequenced, only
9 passed the threshold of MAPD of % 0.45; one of these ninethors
neurons was positive for the chromosome 1q CNV (Figure 2C),
and eight showed normal CN for 1q (Table S1). Despite these
limitations, CNV analysis showed clear tetrasomy of chromo-
some 1q (CN = 4) rather than the expected trisomy (CN = 3).
Additional NeuN+ and NeuN cells with higher MAPD scores
confirmed the CN gain of 1q as a tetrasomy, rather than trisomy
(Figure 2C). Tetrasomy of 1q was previously described in
a mosaic state in humans with nasopharyngeal teratomas
(Beverstock et al., 1999) as an isodicentric chromosome 1q
[47, XX, +idic(1)(q10)]. Although FISH was not possible in this
poorly preserved tissue, two different HMG samples (HMG-1
and HMG-2) show the exact same chromosome 1q gain with
a centromeric breakpoint, suggesting they share the same iso-
dicentric chromosome 1q tetrasomy. This surprising result high-
lights the power of single-cell analyses to define CN states of
somatic mutations.
Subchromosomal CNV Analysis of Single Normal
Neurons
In order to optimize CNV calling, we performed CNV analysis
at subchromosomal resolution in 24 single lymphoblasts and
four ten-cell samples of cultured lymphoblasts derived from
a normal male (GM21781). Unamplified DNA at the same
passage was sequenced at the same read depth as ampli-
fied single-cell and ten-cell samples (average read depth
of 1.5 million unique reads per sample). A nonreference
2.15 Mb CN gain at distal chromosome Xp was identified in
the bulk sample (Figure S3A) and validated in WGS data
from the Personal Genome Project from this individual
(https://my.pgp-hms.org/profile/huAE6220) (Ball et al., 2012).
The same CN gain was called in four out of four ten-cell
samples and 15 out of 24 one-cell samples, demonstrating
reasonable sensitivity in detecting subchromosomal CNVs
down to 2 Mb resolution from single cells amplified by
GenomePlex (Figure S3A). Additional high-confidence CNVs
were shared by multiple single-cell samples but were absent
or present at a low level from bulk and ten-cell samples,
demonstrating sensitive detection of clonal, mosaic CNVs
down to 1–2 Mb (Figure S3B).
Among 24 single lymphoblasts, an average of 6.7 candidate
CNVs were identified per sample, including 3.9 CN gains and
2.8 losses per sample, with 30% of the candidate CNV events
identifiable in more than one single-cell sample (Figure 3; see
also Figure S3). A small fraction of samples showedmany events
(Figures 4A and 4B), but the number of CNVs identified in each
single cell sample was not correlated with MAPD score (Fig-
ure S4). CNVs ranged from 1.3 Mb to 22.9 Mb, with a median
of 2.4 Mb across all samples (Figure 4C). While we did not
perform extensive validation of private candidate CNVs, the sin-
gle-cell CNV analysis shows that germline CNVs, shared clonal
CNVs, and private candidate CNVs as small as 2 Mb can be
identified in single-cell genomes with GenomePlex, confirming
other reports that somatic CNVs are common in cultured cells
(Abyzov et al., 2012).
The sameCNVanalysis performedon19euploid single cortical
neurons amplified by GenomePlex showed an average of 3.4
candidate CNVs per single neuron, with 31% (6/19) of neurons
lacking large CNVs (Figures 4A and 4B). Neuronal CNVs wereCell Repredominately CN losses, with only 1 gain out of 65 candidate
CNVs (Figures 4A and 4C). The size of candidate neuronal
CNVs was similar to lymphoblasts, (median 2.3 Mb; range 1.7–
17 Mb) (Figure 4B). Only two CNVs (6%) identified from single
neurons were shared, each by two neurons (Figures 3B, 3C,
and 4A). Nonetheless, sharing of CNVs by neurons validates
them and suggests that large CNVs may arise in progenitor cells
during normal brain development, consistentwith the pathogenic
CNV inHMG. Finally, we investigatedwhether any of the neuronal
candidate CNVs correspond to known recurrent CNVs and iden-
tified a 2.9Mb gain at 15q13.2-13.3 (Figure 3D), which overlaps a
recurrent CNV associated with autism and other neuropsychi-
atric disorders (Sanders et al., 2011; Sebat et al., 2007).
DISCUSSION
Our data confirm that somatic CNVs occur in the brain and that
large-scale CNVs can be detected at a single-neuron level
(McConnell et al., 2013) but extend these findings to show that
CNVs can be shared by multiple neurons, both in pathological
(HMG) and normal brain, showing that CNVs can be generated
during neurogenesis and inherited clonally. Clonal CNV inheri-
tance provides important validation for CNV calls, addresses
the mechanism of CNV formation, and provides a mechanism
whereby single CNV events could be shared by many neurons
and hence be potentially deleterious.
Detection of CNVs in single neurons is inherently challenging,
since all methods for analysis of single cells require amplification,
so that the unperturbed state of the single neuronal genome
cannot be queried. Several lines of evidence suggest that
many of our candidate CNV calls are bona fide. First, single-
cell WGS is highly sensitive and specific in detecting germline
tri18 as well as the single Y chromosome in males, showing
that the method detects large CNVs. Second, the method de-
tects a clonal, somatic subchromosomal CNV of chromosome
1q associated with HMG that was independently discovered
bymicroarray and qPCR analysis of unamplified brain tissue (Po-
duri et al., 2012). Third, GenomePlex (Baslan et al., 2012; Navin
et al., 2011) can identify candidate CNVs in cultured lympho-
blasts, including a germline CNV that was independently verified
by analysis of unamplified DNA, andmosaic clonal CNVs that are
shared by multiple single cells and technical controls. Finally, we
identify candidate CNVs in single neurons and show that two of
these are shared by two neurons each, providing independent
validation of each CNV in a second cell and suggesting that
some CNVs are generated during brain development.
Methodologies for single-cell genome amplification and anal-
ysis are rapidly evolving, and several different methods are
available, such as MALBAC (Zong et al., 2012) and MIDAS
(Gole et al., 2013). The MAPD score allows quantitative analysis
of uniformity of amplification, adding a universal marker to
compare different single-cell amplification methods to other
standard metrics such as genome coverage, GC bias, and
allele dropout. The MAPD metric quantitated how GenomePlex
provided more even genome amplification, and more accurate
CNV calls, as shown by others (Navin et al., 2011; Van der Aa
et al., 2013). In our hands, MDA amplifies virtually the entire





Figure 2. Chromosomal Aneuploidy and CNV Analysis of Single Neurons from Trisomy 18 and 1q CNV Brains
(A) All nine single neuron genomes with germline trisomy 18 showed CN increase at chromosome 18. Chromosome CN of single cortical neurons from a tri18
(UMB866, 47XY, +18) individual demonstrates 100% sensitivity in detecting the CN gain at chromosome 18. CNs are normalized to the median CN of each
chromosome across the five wild-type single neurons, with autosomes adjusted to a median CN of 2. Orange line denotes CN 3.
(legend continued on next page)
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overcome the nonuniformity of amplification and hence can
only resolve large CNVs. Nonetheless, MDA detects tri18 accu-
rately (average CN of nine cells = 3.01), suggesting that the
nonuniformities of MDA are smoothed out over larger genomic
regions and after computationally controlling for GC bias.
Although megabase-range somatic CNVs are seen in both
cultured lymphoblasts and wild-type neurons, the CNV land-
scape differs between the two cell types. CNVs from lympho-
blasts are more frequently clonal, whereas neuronal CNVs are
more often private. This difference could be technical, but likely
reflects cultured lymphoblasts’ continuous proliferation with
ongoing generation of clonal CNVs, whereas the postmitotic na-
ture of adult neurons only allows clonal CNVs to develop during
development. On the other hand, we show that clonal CNVs can
cause HMG, and clonal CNVs also occur occasionally in normal
neurons, suggesting that some CNVs occur during develop-
ment. Candidate neuronal CNVs in our data show a similar size
range as lymphoblast CNVs but are biased toward losses
compared to gains (McConnell et al., 2013). Although some
candidate CNVs may reflect amplification dropout artifacts, the
neuron-lymphoblast differences suggest that distinct molecular
mechanisms regulate formation of CNVs in these two cell types.
Single-cell WGS showed that the 1q CNV in an HMG sample
was likely a tetrasomy rather than a trisomy and hence present
in fewer cells than initially suspected (33% of non-neuronal
cells and <20% of neurons), illustrating how a clonal somatic
CNV in a minority of brain cells can cause widespread dysfunc-
tion (Poduri et al., 2012). Other brain malformations with intrac-
table epilepsy are associated with SNVs in as few as 10%of cells
assayed in blood or in brain (Gleeson et al., 2000; Jamuar et al.,
2014; Kurek et al., 2012; Lee et al., 2012; Poduri et al., 2012,
2013). De novo CNVs are commonly associated with neuropsy-
chiatric disease (Gilman et al., 2011; Levy et al., 2011; Sanders
et al., 2011; Sullivan et al., 2012), and one candidate single-cell
CNV gain (Figure 3D) involves proximal chromosome 15q, a re-
gion subject to recurrent CNV associated with neuropsychiatric
disease. If such clonal CNVs occur early in development, they
could involve enough cells to cause neuropsychiatric disease
and yet be difficult to detect in blood.
EXPERIMENTAL PROCEDURES
Tissue Sources and Cell Isolation
Fresh-frozen postmortem tissue of three normal individuals (UMB1465,
UMB4638, and UMB4643) and a tri18 fetus (UMB866) were obtained from
the National Institute of Child Health and Human Development Brain and Tis-
sue Bank for Developmental Disorders at the University of Maryland (Balti-
more, MD). Fresh-frozen brain tissue of an HMG brain (HMG-1) was obtained
in accordance with requirements of the institutional review boards of Boston
Children’s Hospital and Beth Israel Deaconess Medical Center. An Epstein-
Barr virus-transformed B-lymphoblast cell line GM21781, derived from a
normal individual (PGP8, huAE6220) from the Personal Genome Project, was
obtained from Coriell Cell Repositories and cultured with RPMI 1640 + 15%
fetal bovine serum + 2 mM L-glutamine. Isolation of single nuclei from primary(B) The 100-cell samples from HMG-1 brain, carrying a clonal 1q CNV, show that
(red arrow). Gray dots denote CN of each genomic bin, and black lines denote them
(C) CN plots at chromosome 1 of single-cell samples from both the NeuN+ and
normal CN 2 in the rest of the samples. Blue and orange lines denotemedian CN of
and the orange line represents chromosome arms with CN 4.
Cell Rebrain tissues and quality assessments were performed as described previ-
ously (Evrony et al., 2012). Single cells from B-lymphoblast suspension cul-
tures were suspended in 13 PBSwith 13 live-cell DNA dye DRAQ5, incubated
at 37C for 5 min per the manufacturer’s instruction (Cell Signaling Tech-
nology), then sorted into 96-well PCR plates preloaded with lysis buffer.
scWGA by MDA and GenomePlex
All scWGAwas carried out in aUV-treated laminar flowcabinet, andall surfaces,
plastics, and nonbiologic buffers were UV treated for at least 30 min. MDA was
performed as previously described (Evrony et al., 2012). GenomePlex-WGA4
was performed according to the manufacturer’s instructions (Sigma-Aldrich),
with some modification to the lysis condition and reaction volume. Individual
cells and pooled 10-cell and 100-cell controls were sorted into 96-well plates
preloaded with 4 ml alkaline lysis buffer (100 mM KOH, 5 mM EDTA, 40 mM
dithiothreitol), and neutralized with 1 ml neutralization buffer (400 mM HCl,
600 mM Tris [pH 7.5]). Fragmentation, adaptor ligation, and PCR amplification
were performed according to manufacturer’s instruction with all reaction vol-
umes reduced by half. Amplified products were purified with AMPureXP beads
and quantified by nanodrop. Amplification quality and contamination were
assessed by 1.5% agarose gel electrophoresis of 5% of the product. Samples
with no visible product were excluded from library preparation. Four-locus
multiplex PCR was performed on all MDA-amplified samples as described
previously (Evrony et al., 2012). Samples with less than three loci amplified
were generally excluded. Three single-neuron samples with one or two loci
amplified were included in library preparation and sequencing to test the
effectiveness of multiplex-PCR as a quality control.
Whole-Genome Sequencing
WGS libraries prepared from 500 ng of DNA with the NEXTflex DNA
sequencing kit (Bioo Scientific) were barcoded for multiplexed sequencing
at the Harvard Biopolymers Facility (HarvardMedical School) and TUCFGeno-
mics Center (Tufts Medical School) on HiSeq 2000 sequencers (Illumina). For
low-coverage sequencing, 32 samples were multiplexed into each HiSeq lane
for single-end 50 bp runs, obtaining 5 million pass-filter reads per sample.
CNV Analysis
The CNV analysis is adapted and modified from Baslan et al. (2012). Equal-
read bins with variable sizes (6,000, 20,000, and 50,000) were created
based on simulated reads from the hg19 reference genome (Baslan et al.,
2012; Navin and Hicks, 2011) with median bin sizes of 458 kb, 137 kb, and
54 kb, respectively. Generating equal-read instead of ‘‘equal-size’’ genomic
bins controls for read mappability so that each bin receives the same number
of mappable positions, and hence similar read counts from each bin are
expected from low-coverageWGS. The percentage GC content of each calcu-
lated bin (GCi, where i stands for individual bins) was computed for GC
normalization.
All sequence reads were demultiplexed by CASAVA, allowing for one
mismatch in the 6 bp index sequences. Sequence reads were mapped with
bowtie with the following settings: bowtie -v 2 -m 1–best–strata (Langmead
et al., 2009). PCR duplicates were removed using SAMTools (Li et al., 2009).
Reads per bin (RPBi) for each sample were computed and the CN ratio
(CNRi) for each bin was calculated as CNRi = RPBi/Median(RPB), where i
stands for individual bins. CNRi was further normalized based on the GC
content of each bin (GCi) to yield the GC-normalized CN ratios (nCNRi).
MAPD Metrics
The MAPD QC metric was developed by adapting the Affymetrix multiple
absolute pairwise differences algorithm (Affymetrix, 2008): MAPD =
Median(jlog2nCNRi+1  log2nCNRij), where i stands for individual bins. A
MAPD threshold of 0.45 was used for all single-cell samples. All three MDAboth NeuN+ and NeuN populations showed noninteger CN increase at chr1q
ediumCNof each chromosome arm. Orange dashed lines denote CN 1 and 3.
NeuN populations showed four copies of chr1q in a fraction of samples and
each chromosome arm. The blue line represents chromosome armswith CN 2,
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Figure 3. Mosaic Clonal CNVs Identified from Normal Lymphoblast Cells and Neurons
(A) Example of a clonal CNV identified from lymphoblast GM21781. A 1.9Mb CN gain at chr9 (chr9: 4,250,567–6,148,270) (indicated by red arrow) shared
by multiple lymphoblasts (also see Figure S3B). Gray dots denote raw CN of each bin, and the blue line denotes the segmentation means of each
CN segment, used for CN calls. The gray rectangle roughly defines boundaries of centromere. The bottom panel overlays CN calls of both single
lymphoblasts.
(B) Clonal CNV identified in UMB4643 cortical neurons. A 1.9 Mb CN loss at chr8 (chr8: 100,204,912–102,089,812) (indicated by red arrow) is shared
by two single neurons from 4643 cortex. The bottom panel overlays CN calls of both single neurons. A false-positive call at the centromere was filtered from the
final call set.
(legend continued on next page)
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Figure 4. Comparative CNV Landscape in
Lymphoblasts and Cortical Neurons
(A) Pie chart summarizes CNVs identified from
single lymphoblasts versus single neurons.
Approximately 30% (18% CN gains and 12%
losses) of CNVs identified from single lympho-
blasts are clonal, whereas only 6% (6% CN losses
and 0% gain) of CNVs identified from single neu-
rons are clonal. CNVs identified from single neu-
rons are predominately private losses, whereas
CNVs identified from single lymphoblasts are
balanced between losses and gains.
(B) Histogram of total candidate CNVs identified in
each single cell. Left: histogram of CNVs identified
in each single lymphoblast (n = 24) shows that
most single cells harbor less than five CNVs,
though three outlier cells show larger numbers.
The red dashed line shows the average CNVs per
lymphoblast (6.7). Right: histogram of CNVs iden-
tified in each single neuron (n = 19), showing that
most single neurons harbor less than five CNVs,
with three outliers showing larger numbers. The
red dashed line represents the average number of
CNVs per neuron at 3.4.
(C) Size distribution of CNVs identified from single
cells. Left: size distribution of all CNVs identified
in single lymphoblasts (n = 160). Most are less than
5 Mb with one outlier at 22 Mb, without obvious
differences in size distribution between losses
(green bars) and gains (red bars). Right: size dis-
tribution of CNVs identified in single neurons
(n = 65). Most are <5 Mb with one outlier at 18 Mb.
The only gain (red bar) identified is on the small end
of the size distribution.single-cell samples that failed the initial multiplex-PCR QC exhibited very high
MAPD scores, confirming that multiplex-PCR can serve as a first-pass QC
method that eliminates some, but not all, poor-quality samples.
Chromosomal CN Calling
Chromosome CN ratios for each chromosome arm were calculated as the
fraction of reads in each sample aligning to the chromosome arm, normalized
to method-specific normalizer reference sets. Raw read counts for each chro-
mosome and chromosome arm were obtained by SAMTools (Li et al., 2009)
using hg19 centromere coordinates obtained from the UCSC genome data-(C) Clonal CNV identified in UMB4643 cortical neurons. A2.3MbCN loss at chrX (chrX: 51,160,992–53,500,7
neurons from 4643 cortex. The bottom panel compares CN calls of both single neurons, emphasizing that t
(D) 15q13 duplication identified in a single UMB4643 cortical neuron. An 3 Mb CN gain at chr15 (chr15:
identified in a single neuron from UMB4643 cortex, overlaps the site of a recurrent CNV associated with ASD.
cortex 1-cell_24 on chromosome 15.
Cell Reports 8, 1280–1289, Sepbase. For MDA samples, the median fraction of
reads aligning to each chromosome arm across
five euploid cortical neurons from normal individ-
ual UMB1465 was used as the normalizer refer-
ence set. For GenomePlex samples, four ten-cell
samples from GM21781 lymphoblasts were used
as the normalizer reference set. For autosomal
chromosomes, chromosomeCN ratios weremulti-
plied by two to obtain the absolute CN of the
diploid genome. Sex chromosome CNs were
determined by their CN ratios to the autosomeswithin each sample. The final CN of each chromosome arm or chromosome
were obtained by rounding to their nearest integer.
CNV Calling
For CNV calls, the GC-normalized CN ratios (nCNRi) were log2 transformed
and segmented using the circular-binary segmentation (CBS) algorithm pro-
vided in the DNAcopy package under the following settings: alpha = 0.02,
nperm = 1000, undo.splits = ’’sdundo,’’ undo.SD = 1.0, min.width = 5 (Baslan
et al., 2012; Venkatraman and Olshen, 2007). CNVs were called based
on the absolute distance between the segment mean of each genomic96) (indicated by red arrow) is shared by two single
hey are closely in register.
30,231,607–33,177,781) (indicated by red arrow),
The bottom panel shows the CN calls of UMB4643
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segment and the median segment mean across all segments of each sample:
Seg.distj = jSeg.meanjMedian(Seg.mean)j, where j stands for individual seg-
ments. A CNVwas called if a given genomic segment met the following criteria:
(1) Seg.distj R 2 MADs (median absolute distance) of the segment means
of the sample; (2) p value of the segment mean being different from the
median segment mean across all segments <0.1 based on one-tail Z-test:
pnorm(Seg.distj/sd(Seg.mean)) R 0.9; (3) spans four or more genomic bins;
(4)R1 Mb in size; and (5) does not overlap with centromere regions. All these
parameters were empirically calibrated to obtain >60% detection of a 2.7 Mb
germline CNV in GM21781 single lymphoblast samples (Figure S3). Further in-
crease of CNV calling stringency resulted in reduced sensitivity, while further
decreasing the calling stringency produced excessive private CNV calls with
noninteger segment means, suggestive of false positives. Finally, the segment
mean of called events was converted to diploid genome CN and rounded to
the nearest integer to represent the final CN. For male samples, sex chromo-
somes were treated separately from autosomes. Clonal CNVs were identified
by searching for CNV calls between different samples that share at least two
genomic bins; the p value for such events to happen by chance is <104 based
on an ANOVA multisample test.
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